[go: up one dir, main page]

CL2008003809A1 - Composicion en polvo nutricional que comprende carboidratos, lipidos con 0,25 a 2,5% de lecitina, 90 a 99,5% de proteina intacta y 0,5 a 10% de proteina de suero con un grado de hidrolisis de entre 23 y 90%; y composiciones nutricionales para bebes. - Google Patents

Composicion en polvo nutricional que comprende carboidratos, lipidos con 0,25 a 2,5% de lecitina, 90 a 99,5% de proteina intacta y 0,5 a 10% de proteina de suero con un grado de hidrolisis de entre 23 y 90%; y composiciones nutricionales para bebes.

Info

Publication number
CL2008003809A1
CL2008003809A1 CL2008003809A CL2008003809A CL2008003809A1 CL 2008003809 A1 CL2008003809 A1 CL 2008003809A1 CL 2008003809 A CL2008003809 A CL 2008003809A CL 2008003809 A CL2008003809 A CL 2008003809A CL 2008003809 A1 CL2008003809 A1 CL 2008003809A1
Authority
CL
Chile
Prior art keywords
protein
nutritional
lecithin
hydrolysis
degree
Prior art date
Application number
CL2008003809A
Other languages
English (en)
Inventor
Christine L Clinger
Jeffrey M Boff
Paul W Johns
Gary E Katz
Marti S Bergana
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40788959&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008003809(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of CL2008003809A1 publication Critical patent/CL2008003809A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/10Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composición que comprende carbohidrato, lípido con 0,25-2,5% de lecitina en peso de lípido total, 90-99,5% de proteína intacta y 0,5-10% de proteína hidrolizada seleccionada de caseína hidrolizada y proteína de suero hidrolizada en peso de proteína total, con un grado de hidrólisis entre 23-90%, la composición es polvo nutricional.
CL2008003809A 2007-12-20 2008-12-18 Composicion en polvo nutricional que comprende carboidratos, lipidos con 0,25 a 2,5% de lecitina, 90 a 99,5% de proteina intacta y 0,5 a 10% de proteina de suero con un grado de hidrolisis de entre 23 y 90%; y composiciones nutricionales para bebes. CL2008003809A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1531807P 2007-12-20 2007-12-20

Publications (1)

Publication Number Publication Date
CL2008003809A1 true CL2008003809A1 (es) 2009-10-16

Family

ID=40788959

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008003809A CL2008003809A1 (es) 2007-12-20 2008-12-18 Composicion en polvo nutricional que comprende carboidratos, lipidos con 0,25 a 2,5% de lecitina, 90 a 99,5% de proteina intacta y 0,5 a 10% de proteina de suero con un grado de hidrolisis de entre 23 y 90%; y composiciones nutricionales para bebes.

Country Status (25)

Country Link
US (1) US8377496B2 (es)
EP (1) EP2242382B1 (es)
JP (1) JP2011507518A (es)
CN (1) CN101951789B (es)
AR (1) AR070679A1 (es)
AU (1) AU2008343689A1 (es)
BR (1) BRPI0820584A2 (es)
CA (1) CA2708527C (es)
CL (1) CL2008003809A1 (es)
CO (1) CO6280447A2 (es)
CR (1) CR11508A (es)
DO (1) DOP2010000176A (es)
EC (1) ECSP10010262A (es)
GT (1) GT201000173A (es)
IL (1) IL206132A (es)
MX (1) MX2010006887A (es)
MY (1) MY168206A (es)
NZ (1) NZ585619A (es)
PA (1) PA8808701A1 (es)
PE (1) PE20091332A1 (es)
RU (1) RU2481008C2 (es)
SV (1) SV2010003599A (es)
TW (1) TWI418307B (es)
WO (1) WO2009085388A2 (es)
ZA (1) ZA201003912B (es)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007079147A2 (en) 2005-12-28 2007-07-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
WO2008076975A1 (en) 2006-12-18 2008-06-26 Advanced Bionutrition Corporation A dry food product containing live probiotic
WO2009126932A2 (en) * 2008-04-10 2009-10-15 Provide Nutrition Fortified liquid protein compositions and methods of making same
CA2756883C (en) 2009-03-27 2018-01-09 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
US20120100208A1 (en) 2009-04-29 2012-04-26 Amarin Pharma, Inc. Stable pharmaceutical composition and methods of using same
MY205872A (en) 2009-04-29 2024-11-18 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising omega-3 fatty acids
JP5841527B2 (ja) 2009-05-26 2016-01-13 アドバンスド バイオニュートリション コーポレーション 生物学的に活性な微生物および/または生物活性材料を含む安定な乾燥粉末組成物およびその製造方法
AU2010260129B2 (en) 2009-06-15 2014-05-29 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels
TW201112967A (en) * 2009-09-16 2011-04-16 Abbott Lab Dryblended nutritional powders
BR112012006692B8 (pt) 2009-09-23 2021-05-25 Amarin Corp Plc composição farmacêutica compreendendo um derivado de hidróxi de atorvastatina e um óleo compreendendo etil eicosapentaenoato ou etil docosahexaenoato
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
AR080073A1 (es) 2010-01-28 2012-03-14 Advanced Bionutrition Corp Composicion vitrea seca que comprende un material bioactivo
US8840950B2 (en) * 2010-05-26 2014-09-23 Jacqueline M. Hibbert Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
SG187250A1 (en) 2010-08-13 2013-03-28 Advanced Bionutrition Corp Dry storage stabilizing composition for biological materials
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
NZ727980A (en) 2010-11-29 2018-08-31 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
CN102599402B (zh) * 2011-01-25 2013-09-04 光明乳业股份有限公司 一种乳清蛋白组合物及其制备方法
ES2689225T3 (es) * 2011-02-07 2018-11-12 Abbott Laboratories Productos nutricionales que comprenden beta-hidroxi-beta-metilbutirato
CN102273520B (zh) * 2011-08-02 2013-08-07 中国科学院新疆理化技术研究所 乳清营养粉及其制备方法
US20130089638A1 (en) * 2011-10-11 2013-04-11 Mead Johnson Nutrition Company Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
MX370851B (es) * 2011-10-14 2020-01-08 Abbott Lab Suplemento de proteína líquida esterilizada.
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US9827219B2 (en) 2012-01-06 2017-11-28 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity C-reactive protein (HS-CRP) in a subject
WO2013142792A1 (en) * 2012-03-23 2013-09-26 Advanced Bionutrition Corporation Stabilizing composition for biological materials
PT4338805T (pt) 2012-06-29 2025-09-02 Amarin Pharmaceuticals Ie Ltd Éster etílico do ácido eicosapentanoico para utilização na redução do risco de enfarte do miocárdio não fatal num indivíduo em terapia com estatina
US20150265566A1 (en) 2012-11-06 2015-09-24 Amarin Pharmaceuticals Ireland Limited Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US20140328970A1 (en) * 2013-05-03 2014-11-06 Mead Johnson Nutrition Company Nutritional Composition Comprising Whey and Hydrolyzed Casein and Uses Thereof
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10639334B2 (en) * 2014-01-07 2020-05-05 Mead Johnson Nutrition Company Pediatric nutritional composition with milk peptides for healthy growth and development
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
CN106659223A (zh) * 2014-07-21 2017-05-10 雅培制药有限公司 具有特定抗氧化剂的营养粉末
WO2016014514A1 (en) * 2014-07-21 2016-01-28 Abbott Laboratories Nutritional powder with polyunsaturated fatty acid and improved organoleptic properties
WO2016113613A1 (en) * 2015-01-16 2016-07-21 Welldrinks Ltd Beverage with collagen and additional additives
US10953050B2 (en) 2015-07-29 2021-03-23 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
PL3362061T3 (pl) * 2015-10-15 2024-03-04 N.V. Nutricia Mieszanka dla niemowląt z tłuszczem mlecznym wspomagająca zdrowy wzrost
US11129404B2 (en) 2015-12-28 2021-09-28 Abbott Laboratories Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof
WO2017136197A1 (en) * 2016-02-05 2017-08-10 Abbott Laboratories Whey protein based liquid nutritional composition
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10966951B2 (en) 2017-05-19 2021-04-06 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
PL4056176T3 (pl) 2018-09-24 2024-08-26 Amarin Pharmaceuticals Ireland Limited Sposoby zmniejszania ryzyka zdarzeń krążeniowo-naczyniowych u osobnika
US12426615B2 (en) 2019-02-21 2025-09-30 Ingenuity Foods, Inc. Compositions comprising choline and omega-3 fatty acid to nutritionally enhance food products
KR20220122616A (ko) 2019-11-12 2022-09-02 애머린 파마슈티칼스 아일랜드 리미티드 심방 세동 및/또는 심방 조동을 갖는 대상체에서 심혈관 사건의 위험을 감소시키는 방법
EP4326244A4 (en) 2021-04-21 2025-03-19 Amarin Pharmaceuticals Ireland Limited METHODS TO REDUCE THE RISK OF HEART FAILURE
CN113632993A (zh) * 2021-08-24 2021-11-12 黑龙江八一农垦大学 黑豆-乳清双蛋白运动营养粉
CN116965483A (zh) * 2023-07-21 2023-10-31 广州白云山汉方现代药业有限公司 一种氧化稳定性好的蛋黄磷脂组合物及应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5024849A (en) 1990-05-01 1991-06-18 Nestec S.A. Liquid coffee whitener
US5021245A (en) * 1990-05-22 1991-06-04 Abbott Laboratories Infant formula containing a soy polysaccharide fiber source
CA2089920C (en) 1992-02-21 1999-06-15 John D. Johnston Synergistic compositions for extending animal feed shelf life
NL9300848A (nl) 1993-05-14 1994-12-01 Friesland Frico Domo Coop Werkwijze voor de bereiding van lang houdbare melkconcentraten en melkpoeders.
US5405637A (en) * 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
ATE409483T1 (de) * 1994-01-10 2008-10-15 Abbott Lab Enterale zusammensetzung mit ribo-nucleotiden
US6136858A (en) * 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
US5635199A (en) 1995-10-27 1997-06-03 Nestec Ltd. Support of pediatric patients
EP1039892B1 (en) 1997-02-21 2004-04-28 Abbott Laboratories Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
EP1034704A1 (en) 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
US6294206B1 (en) 1999-04-09 2001-09-25 Abbott Laboratories Powdered human milk fortifier
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US6207638B1 (en) * 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
ES2291406T3 (es) * 2001-11-26 2008-03-01 Nestec S.A. Composicion nutritiva auto-estable, que contiene proteina de suero lacteo, intacta, procedimiento de fabricacion y uso.
RU2262867C2 (ru) * 2002-02-14 2005-10-27 Катков Юрий Адольфович Бад к пище для улучшения репродукции человека (варианты)
US7070825B2 (en) 2002-09-10 2006-07-04 Abbott Laboratories Infant formula
TWI317636B (en) * 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
WO2005089255A2 (en) 2004-03-12 2005-09-29 Nellson Northern Operating Inc. Novel protein layering masses, processes for the manufacture thereof, and related products
EP1839492B1 (en) 2006-03-27 2011-09-14 Nestec S.A. Whey protein micelles
CA2537647A1 (en) 2005-03-01 2006-09-01 Six Star Formulations Ltd. Supplemental dietary composition for supporting muscle growth, recovery and strength
US20060233915A1 (en) 2005-04-15 2006-10-19 Bristol-Myers Squibb Company Liquid nutritional product to supplement human milk
US7618669B2 (en) 2005-06-01 2009-11-17 Mead Johnson Nutrition Company Low-lactose partially hydrolyzed infant formula
DE102005031468A1 (de) 2005-07-04 2007-01-18 Basf Ag Wässrige Suspensionen schwer wasserlöslicher oder wasserunlöslicher Wirkstoffe und daraus hergestellte Trockenpulver
BRPI0621481A2 (pt) 2006-03-23 2011-12-13 Nestec Sa suplemento nutricional de alta caloria
US7875303B2 (en) * 2006-03-31 2011-01-25 Kraft Foods Global Brands Llc Protein system and food products including same
US20070281054A1 (en) 2006-05-31 2007-12-06 Abbott Laboratories Organic powder nutritional formula containing select carbohydrate combinations
WO2010047581A1 (en) 2008-10-24 2010-04-29 N.V. Nutricia Liquid high-fat protein composition

Also Published As

Publication number Publication date
AR070679A1 (es) 2010-04-28
MX2010006887A (es) 2010-10-15
US8377496B2 (en) 2013-02-19
EP2242382A2 (en) 2010-10-27
NZ585619A (en) 2012-06-29
AU2008343689A1 (en) 2009-07-09
ZA201003912B (en) 2011-06-29
EP2242382B1 (en) 2016-11-16
CO6280447A2 (es) 2011-05-20
WO2009085388A2 (en) 2009-07-09
BRPI0820584A2 (pt) 2015-07-14
RU2010129984A (ru) 2012-01-27
MY168206A (en) 2018-10-15
SV2010003599A (es) 2011-01-24
DOP2010000176A (es) 2010-10-15
CR11508A (es) 2011-08-12
WO2009085388A3 (en) 2010-09-02
JP2011507518A (ja) 2011-03-10
CA2708527C (en) 2016-06-14
TW200932128A (en) 2009-08-01
CN101951789A (zh) 2011-01-19
GT201000173A (es) 2012-04-03
IL206132A (en) 2014-04-30
US20090162518A1 (en) 2009-06-25
RU2481008C2 (ru) 2013-05-10
PE20091332A1 (es) 2009-09-30
CN101951789B (zh) 2014-02-05
TWI418307B (zh) 2013-12-11
CA2708527A1 (en) 2009-07-09
IL206132A0 (en) 2010-11-30
ECSP10010262A (es) 2010-07-30
PA8808701A1 (es) 2009-07-23

Similar Documents

Publication Publication Date Title
CL2008003809A1 (es) Composicion en polvo nutricional que comprende carboidratos, lipidos con 0,25 a 2,5% de lecitina, 90 a 99,5% de proteina intacta y 0,5 a 10% de proteina de suero con un grado de hidrolisis de entre 23 y 90%; y composiciones nutricionales para bebes.
CL2008003807A1 (es) Composicion en polvo nutrifcional que comprende carbhidratos, lipidos con 0,25 a 2,5% de lecitina, 0,5 a 10% de proteina hidrolizada y 90 a 99,5% de proteina intacta; y composiciones nutricionales para bebes.
CL2007002084A1 (es) Ingrediente lacteo enriquecido en fosfolipidos y esfingolipidos, en que el porcentaje de fosfolipidos es mayor a 36% con respeto al peso de la materia seca del ingrediente; procedimiento de obtencion; composicion alimentaria o aditivo que lo contiene; composicion farmaceutica o cosmetica; y su uso.
PE20151765A1 (es) Formulas a base de hidrolizado de aminoacido y proteina con un sistema estable de emulsion
BR112013020940A2 (pt) produto de proteína de soro de leite, método de produção e uso
CL2011003078A1 (es) Uso de una composicion nutricional para mantener, sostener y/o mejorar el desempeno cognitivo en un nino de 3 a 6 anos, que comprende al menos una fuente de proteina, una fuente de carbohidratos, una fuente de lipido, un microorganismo probiotico, y prebioticos, en donde la fuente de lipido comprende acido docosahexanoico (dha).
BR112012031183A2 (pt) líquidos nutricionais substancialmente claros compreendendo proteína de cálcio hmb e solúvel
CL2011000893A1 (es) Composicion nutricional para infantes en que comprende proteinas parcialmente hidrolizadas con un grado de hidrolisis de entre 5 y 40%, una fuente de lipido y una fuente de carbohidrato seleccionado entre almidon de cereal o de papa; y su uso para el manejo de la regurgitacion.
CO6630181A2 (es) Composiciones y métodos para uso de anticuerpos terapéuticos de lrp6( proteina relacionada con lipoproteínas de baja densidad 6)
BR112015014237A2 (pt) composição nutricional oral com alta densidade calórica e baixa viscosidade e métodos relacionados
BR112012017683A2 (pt) Emulsões nutritivas compreendendo hmb de calcio e proteina soluvel
BRPI0814971A8 (pt) Proteína
PH12014500796A1 (en) Partially hydrolyzed casein-whey nutritional compositions for reducing the onset of allergies
CL2008003735A1 (es) Hidrolizado parcial de proteina de cereal con un grado de hidrolisis entre 9 y 18%; proceso de preparacion; harina de cereal; producto de cereal; y uso del hidrolizado parcial de proteinas de cereal.
ECSP13012807A (es) Composición que comprende proteínas de leche termolábiles y proceso para para preparar la misma
PE20141826A1 (es) Uso de composiciones nutricionales que incluyen lactoferrina en apoyo a la resistencia a enfermedades y condiciones
WO2015095570A3 (en) Nutritional composition comprising hydrolyzed protein
PE20141022A1 (es) Composiciones y procedimientos para la administracion de nutrientes
MX2020002167A (es) Formula infantil que tiene un contenido disminuido de proteinas.
BRPI1010340A8 (pt) Manipulador de documento
TH132857A (th) องค์ประกอบโภชนาการ
TH96496S (th) ตู้ใส่เสื้อผ้า
TH38472S1 (th) ตู้ใส่เสื้อผ้า
TH46267S1 (th) รถเกี่ยวข้าว
TH104539S (th) เก้าอี้